Δ9-Tetrahydrocannabinol and Its Major Metabolite Δ9-Tetrahydrocannabinol-11-oic Acid as 15-Lipoxygenase Inhibitors

2011 ◽  
Vol 100 (3) ◽  
pp. 1206-1211 ◽  
Author(s):  
Shuso Takeda ◽  
Rongrong Jiang ◽  
Hironori Aramaki ◽  
Masumi Imoto ◽  
Akihisa Toda ◽  
...  
Keyword(s):  
Major Metabolite ◽  
Lipoxygenase Inhibitors

Effekt des Lipoxygenase-Inhibitors Baicalein auf intakten und osteotomierten Knochen im ovarektomierten Mausmodell

2019 ◽  
Author(s):  
D Saul ◽  
M Weber ◽  
MH Zimmermann ◽  
R Kosinsky ◽  
D Hoffmann ◽  
...  
Keyword(s):  
Lipoxygenase Inhibitors

The effects of cyclooxygenase and lipoxygenase inhibitors on the collagen abnormalities of diabetic rats

Diabetes ◽  
1985 ◽  
Vol 34 (1) ◽  
pp. 74-78 ◽  
Author(s):  
D. K. Yue ◽  
S. McLennan ◽  
D. J. Handelsman ◽  
L. Delbridge ◽  
T. Reeve ◽  
...  
Keyword(s):  
Diabetic Rats ◽  
Lipoxygenase Inhibitors

In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation

2018 ◽  
Vol 21 (3) ◽  
pp. 215-221
Author(s):  
Haroon Khan ◽  
Muhammad Zafar ◽  
Helena Den-Haan ◽  
Horacio Perez-Sanchez ◽  
Mohammad Amjad Kamal
Keyword(s):  
In Silico ◽  
Docking Studies ◽  
In Vivo Studies ◽  
In Vitro Assays ◽  
Chronic Obstructive ◽  
Lipoxygenase Inhibitors ◽  
Lipoxygenase Inhibition ◽  
In Silico Studies

Aim and Objective: Lipoxygenase (LOX) enzymes play an important role in the pathophysiology of several inflammatory and allergic diseases including bronchial asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, rheumatoid arthritis and chronic obstructive pulmonary disease. Inhibitors of the LOX are believed to be an ideal approach in the treatment of diseases caused by its over-expression. In this regard, several synthetic and natural agents are under investigation worldwide. Alkaloids are the most thoroughly investigated class of natural compounds with outstanding past in clinically useful drugs. In this article, we have discussed various alkaloids of plant origin that have already shown lipoxygenase inhibition in-vitro with possible correlation in in silico studies. Materials and Methods: Molecular docking studies were performed using MOE (Molecular Operating Environment) software. Among the ten reported LOX alkaloids inhibitors, derived from plant, compounds 4, 2, 3 and 1 showed excellent docking scores and receptor sensitivity. Result and Conclusion: These compounds already exhibited in vitro lipoxygenase inhibition and the MOE results strongly correlated with the experimental results. On the basis of these in vitro assays and computer aided results, we suggest that these compounds need further detail in vivo studies and clinical trial for the discovery of new more effective and safe lipoxygenase inhibitors. In conclusion, these results might be useful in the design of new and potential lipoxygenase (LOX) inhibitors.

O ‐prenylated carbostyrils as a novel class of 15‐lipoxygenase inhibitors: synthesis, characterization and inhibitory assessment

2021 ◽  
Author(s):  
Seyed Jamal Alavi ◽  
Amir Zebarjadi ◽  
Mahdi Hosseni Bafghi ◽  
Hossein Orafai ◽  
Hamid Sadeghian
Keyword(s):  
Lipoxygenase Inhibitors

scholarly journals Potential Anticancer Lipoxygenase Inhibitors from the Red Sea-Derived Brown Algae Sargassum cinereum: An In-Silico-Supported In-Vitro Study

Antibiotics ◽  
2021 ◽  
Vol 10 (4) ◽  
pp. 416
Author(s):  
Sami I. Alzarea ◽  
Abeer H. Elmaidomy ◽  
Hani Saber ◽  
Arafa Musa ◽  
Mohammad M. Al-Sanea ◽  
...  
Keyword(s):  
Red Sea ◽  
Antiproliferative Activity ◽  
Inhibitory Activity ◽  
Brown Algae ◽  
In Silico ◽  
Active Sites ◽  
In Vitro Study ◽  
Lipoxygenase Inhibitors ◽  
Phytochemical Investigation

LC-MS-assisted metabolomic profiling of the Red Sea-derived brown algae Sargassum cinereum “Sargassaceae” dereplicated eleven compounds 1–11. Further phytochemical investigation afforded two new aryl cresol 12–13, along with eight known compounds 14–21. Both new metabolites, along with 19, showed moderate in vitro antiproliferative activity against HepG2, MCF-7, and Caco-2. Pharmacophore-based virtual screening suggested both 5-LOX and 15-LOX as the most probable target linked to their observed antiproliferative activity. The in vitro enzyme assays revealed 12 and 13 were able to inhibit 5-LOX more preferentially than 15-LOX, while 19 showed a convergent inhibitory activity toward both enzymes. Further in-depth in silico investigation revealed the molecular interactions inside both enzymes’ active sites and explained the varying inhibitory activity for 12 and 13 toward 5-LOX and 15-LOX.

scholarly journals Synthesis and biological evaluation of 2,6-di-tert-butylphenol hydrazones as 5-lipoxygenase inhibitors

1998 ◽  
Vol 6 (2) ◽  
pp. 173-180 ◽  
Author(s):  
Ana M Cuadro ◽  
Jesús Valenciano ◽  
Juan J Vaquero ◽  
Julio Alvarez-Builla ◽  
Carlos Sunkel ◽  
...  
Keyword(s):  
Biological Evaluation ◽  
Lipoxygenase Inhibitors ◽  
Synthesis And Biological Evaluation

scholarly journals Separation and quantification of 2-Keto-3-deoxy-gluconate (KDG) a major metabolite in pectin and alginate degradation pathways

2020 ◽  
pp. 114061
Author(s):  
Shiny MARTIS. B ◽  
Michel DROUX ◽  
Florelle DEBOUDARD ◽  
William NASSER ◽  
Sam MEYER ◽  
...  
Keyword(s):  
Major Metabolite ◽  
Degradation Pathways ◽  
Alginate Degradation
Sign in / Sign up

Export Citation Format

Share Document